In the News

106 News Items found
Young girl
Learn why MSK recommends that children be vaccinated against HPV.
Doctor putting a band-aid on a girl's arm
In the Clinic
3 Things to Know about Cervical Cancer
Learn from gynecologic surgeon Vance Broach about cervical cancer prevention, diagnosis, and treatment.
MSK Physician-in-Chief José Baselga presents at the ASCO meeting
Finding
A clinical trial provides evidence that blocking a protein called PI3K can be an effective treatment strategy for breast cancer.
Physician-scientist Alex Kentsis
In the Lab
Research points to the role of a protein called MYB, which has long been known to play a role in cancer.
DNA molecules wrapped around histones
Feature
Discover some of the most exciting research that Memorial Sloan Kettering scientists are pursuing in the fight against cancer.
Pictured: Craig Thompson
Perspective
Since the signing of the National Cancer Act in 1971, tremendous progress has been made in preventing and treating cancer—though challenges remain.
Detail of an MSK scientist working in a lab
MSK Research Highlights, October 31, 2023
New MSK research identifies a promising immunotherapy target for acute myeloid leukemia; decodes genetic differences in tumors from patients with African ancestry; and finds a virtual mind-body fitness program reduced hospitalizations for those in active cancer treatment. A clinical trial led by MSK also resulted in the approval of a new combination therapy for non-small cell lung cancer.
Ben, Kyle, Charles, and Gloria on a picnic blanket
Meet Ben Hegel, a senior program coordinator in the Sloan Kettering Institute. “My introduction to Pride in college was through a celebratory lens,” says Ben. “But my relationship to Pride has changed.” He still celebrates, but he points out that the Pride March is just that — a march, not a parade. “It was started by marginalized people who were marching for their rights.”
Participants in Cycle for Survival
Treating Rare Cancers
Memorial Sloan Kettering physicians have experience and specialized expertise in caring for people with uncommon cancers.
Michelle Bradbury
Memorial Sloan Kettering researchers will explore "C dots" for tumor detection and treatment.